A Simple Index for Representing the Discrepancy between Simulations of Physiological Pharmacokinetic Models and Experimental Data

Abstract

The objective of this study was to develop an index that would provide a quantitative measure of the degree of discrepancy between simulations of physiologically based pharmacokinetic (PBPK) models and experimental data. The approach we developed involves the calculation of the root mean square of the error (representing the difference between the individual simulated and experimental values for each sampling point in a time course curve), and dividing it by the root mean square of the experimental values. The resulting numerical values of discrepancy measures for several data sets (each corresponding to an end point) obtained in a single experimental study are then combined on the basis of a weighting proportional to the number of data points contained in each data set. Such consolidated discrepancy indices obtained from several experiments (e.g., exposure scenarios, doses, routes, species) are averaged to get an overall discrepancy index, referred to as the PBPK index. This empirical index reflects the overall, weighted average percent difference between the a priori PBPK model simulations and experimental data. The proposed methodology is illustrated using previously published experimental and simulated data on dichloromethane pharmacokinetics in humans. The application of this kind of a "quantitative" method should help remove the ambiguity in communicating the degree of concordance or discrepancy between PBPK model simulations and experimental data.

Get full access to this article

View all access options for this article.

References

Andersen, M.E. , Clewell, H.J., III , Gargas, M.L. , Smith , F.A. , and Reitz, R.H. (1987). "Physiologically-based pharmacokinetics and the risk assessment process for methylene chloride." Toxicol. Appl. Pharmacol. 87:185-205.

Andersen, M.E. , Clewell, H.J. , III, Gargas, M.L. , Mac Naughton, M.J. , Reitz, R.H. , Nolan, R. , and McKenna, M. (1991). "Physiologically based pharmacokinetic modeling with dicloromethane, its metabolite carbon monoxide and blood carboxyhemoglobin in rats and humans." Toxicol. Appl. Pharmacol. 108:14-27.

Bois, F.Y. , Zeise, L. , and Tozer, T.N. (1990). "Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans." Toxicol. Appl. Pharmacol. 102:300-315.

Bois, F.Y. , Woodruff, T.J. , and Spear, R.C. (1991). "Comparison of three physiologically based pharmacokinetic models of benzene disposition." Toxicol. Appl. Pharmacol. 110:79-88.

Farrar, D. , Allen, B. , Crump, K. , and Shipp, A. (1989). "Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output." Tox. Lett. 49:371-385.

Haddad, S. , Gad, S.C. , Tardif, R. , and Krishnan, K. (1995). "Statistical approaches for the validation of physiologically based pharmacokinetic (PBPK) models." Toxicologist 15:48.

Hattis, D. , White, P. , Marmorstein, L. , and Koch, P. (1990). "Uncertainty in pharmacokinetic modeling for perchloroethylene. I. comparison of model parameters, and predictions for low-dose metabolism rates for models drived by different authors." Risk Anal. 10:449-458.

Hetrick, D.M. , Jarabek, A.M. , and Travis, C.C. (1991). "Sensitivity analysis for physiologically based pharmacokinetic models." J. Pharmacokinet. Biopharm. 19:1-20.

Krewski, D. , Wang, Y. , Bartlett, S. , and Krishnan, K. (1995). "Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models." J. Biopharm. Stats . In press.

10.

Krishnan, K. and Andersen, M.E. (1994). "Physiologically based pharmacokinetic modeling in Toxicology." Principles and Methods of Toxicology (W.A. Hayes, ed.). 3rd ed. Raven Press, New York. pp 149-188.

11.

Smith, A.E. and Evans, J.S. (1995). "Uncertainty in fitted estimates of apparent in vivo metabolic constants for chloroform." Fund. Appl. Toxicol . 35:29-43.

12.

Woodruff, T.J. , Bois, F.Y. , Auslander, D. , and Spear, R.C. (1992). "Structure and parametrization of pharmacokinetic models: Their impact on model predictions." Risk Anal. 12:189-201.